[go: up one dir, main page]

ATE315645T1 - DNA OR GENES INVOLVED IN PARKINSON'S DISEASE - Google Patents

DNA OR GENES INVOLVED IN PARKINSON'S DISEASE

Info

Publication number
ATE315645T1
ATE315645T1 AT99902859T AT99902859T ATE315645T1 AT E315645 T1 ATE315645 T1 AT E315645T1 AT 99902859 T AT99902859 T AT 99902859T AT 99902859 T AT99902859 T AT 99902859T AT E315645 T1 ATE315645 T1 AT E315645T1
Authority
AT
Austria
Prior art keywords
disease
parkinson
dna
genes involved
sequence
Prior art date
Application number
AT99902859T
Other languages
German (de)
Inventor
Nobuyoshi Shimizu
Yoshikuni Mizuno
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of ATE315645T1 publication Critical patent/ATE315645T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention provides an isolated DNA or gene that is responsible for Parkinson's disease and is useful in diagnosing and treating the disease etc. The isolated DNA or gene according to this invention comprises a full-length base sequence according to the sequence ID. No. 1 or 2, or a partial sequence thereof, or a base sequence hybridizable thereto or hybridizable with a complemental strand thereof, and being associated with Parkinson's disease.
AT99902859T 1998-02-09 1999-02-09 DNA OR GENES INVOLVED IN PARKINSON'S DISEASE ATE315645T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2753198 1998-02-09

Publications (1)

Publication Number Publication Date
ATE315645T1 true ATE315645T1 (en) 2006-02-15

Family

ID=12223704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902859T ATE315645T1 (en) 1998-02-09 1999-02-09 DNA OR GENES INVOLVED IN PARKINSON'S DISEASE

Country Status (10)

Country Link
US (2) US6716621B1 (en)
EP (1) EP1063294B1 (en)
JP (1) JP4430815B2 (en)
AT (1) ATE315645T1 (en)
AU (1) AU2299999A (en)
CA (1) CA2320220C (en)
DE (2) DE1063294T1 (en)
DK (1) DK1063294T3 (en)
ES (1) ES2257029T3 (en)
WO (1) WO1999040191A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775984B1 (en) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa QUALITATIVE DIFFERENTIAL SCREENING
ATE315645T1 (en) * 1998-02-09 2006-02-15 Boehringer Ingelheim Int DNA OR GENES INVOLVED IN PARKINSON'S DISEASE
CA2996759A1 (en) 1998-11-19 2000-06-02 Aventis Pharma S.A. Mutation of the parkin gene, compositions, methods and uses
EP2305816A1 (en) * 1998-11-19 2011-04-06 Aventis Pharma S.A. Mutation in the Parkin gene, compositions, methods and uses
EP1081225A1 (en) * 1999-08-30 2001-03-07 Biofrontera Pharmaceuticals GmbH Transgenic animal model for neurodegenerative diseases
ES2272444T3 (en) * 2000-02-24 2007-05-01 Boehringer Ingelheim International Gmbh PARKIN PROTEIN, AS UBIQUITINA-LIGASA.
US7399900B2 (en) 2000-03-22 2008-07-15 Sanofi-Aventis Deutschland Gmbh Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode gene
US7070940B2 (en) * 2002-07-18 2006-07-04 Aventis Pharma S.A. Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
US8697082B2 (en) 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
TW200509968A (en) * 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US9034337B2 (en) 2003-10-31 2015-05-19 Prothena Biosciences Limited Treatment and delay of outset of synucleinopathic and amyloidogenic disease
US20080014194A1 (en) 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
WO2005047860A2 (en) 2003-11-08 2005-05-26 Elan Pharmaceuticals, Inc. Antibodies to alpha-synuclein
EP2115159B1 (en) 2007-01-31 2011-12-21 Elan Pharma International Limited Assays for modulators of parkin activity using novel substrates
US8147833B2 (en) 2007-02-23 2012-04-03 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
PL2583978T3 (en) 2007-02-23 2016-07-29 Prothena Biosciences Ltd Co Prevention and treatment of synucleinopathic and amyloidogenic disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE315645T1 (en) * 1998-02-09 2006-02-15 Boehringer Ingelheim Int DNA OR GENES INVOLVED IN PARKINSON'S DISEASE

Also Published As

Publication number Publication date
JP4430815B2 (en) 2010-03-10
DK1063294T3 (en) 2006-05-22
ES2257029T3 (en) 2006-07-16
DE69929417T2 (en) 2006-08-03
WO1999040191A1 (en) 1999-08-12
CA2320220A1 (en) 1999-08-12
AU2299999A (en) 1999-08-23
US6716621B1 (en) 2004-04-06
US20050003385A1 (en) 2005-01-06
DE69929417D1 (en) 2006-04-06
CA2320220C (en) 2011-08-02
EP1063294A4 (en) 2002-01-16
EP1063294B1 (en) 2006-01-11
EP1063294A1 (en) 2000-12-27
DE1063294T1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
DE69929417D1 (en) DNA OR GENES INVOLVED IN PARKINSON'S DISEASE
DK1013661T3 (en) 2'-O, 4'-methylene bicyclonucleoside
DE69840748D1 (en) PROCESS FOR PREPARING ANTISENSE OLIGONUCLEOTIDES
ATE277068T1 (en) 2'-MODIFIED OLIGONUCLEOTIDES WITH RNS ACTION THAT ARE CONFORMALLY RESTRICTED
ATE374836T1 (en) MASS MARKED HYBRIDIZATION PROBE
DE69719220D1 (en) NEW NUCLEOTID ANALOG
BR9705813B1 (en) process for producing nucleoside ester-5'-phosphate, mutant acid phosphatase, isolated gene encoding mutant acid phosphatase.
DE69736840D1 (en) SYNTHESIS OF NUCLEOSIDES AND POLYNUCLEOTIDES
EP0950470A3 (en) Abrasive tool and the method of producing the same
BR9912951A (en) Method of making 1,3-oxathiolane nucleotides
WO2001000661A3 (en) Carnitine carrier related protein-1
CA2195971A1 (en) Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid
DE60026150D1 (en) DIAGNOSTICS AND THERAPEUTICS FOR OSTEOPOROSIS
DE69816059D1 (en) GENE THAT CODES FOR THE PYRUVATE DEHYDROGENASE KINASE OF PLANTS
ATE401403T1 (en) NUCLEOTIDE SEQUENCES INVOLVED IN INCREASE OR DECREASE IN OVULATION SPEED IN MAMMALS
NO995858D0 (en) New class of cationic nucleic acid transfer agents
DE59809600D1 (en) DOUBLE METAL CYANIDE CATALYSTS FOR THE PRODUCTION OF POLYETHER POLYOLS
ATE270331T1 (en) RECEPTOR AND NUCLEIC ACID MOLECULE CODING IT
WO1999066077A3 (en) Methods for the detection of nucleic acids
WO1998022586A3 (en) HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
ATE495027T1 (en) TOOL FOR PRODUCING DECORATIVE PATTERNS ON A COATING MATERIAL
AU2514999A (en) Mood disorder gene
ATA52497A (en) SPEEDOMETER FOR ROLLER SHOES, ROLLBOARDS OR THE LIKE.
ITTO20020364A1 (en) SELF-CERTIFICATION DEPOSIT; ASSIGNMENT LETTER FOLLOWS.
IT1229495B (en) PROCEDURE FOR FINISHING LEATHER, LEATHER AND SIMILAR FIBROUS SUBSTRATES.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1063294

Country of ref document: EP